Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/19/2003EP1362589A1 The use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4- piperidinemethanol for the treatment of sleep disorders
11/19/2003EP1362588A1 Medicinal compositions comprising diclofenac and ornoprostil
11/19/2003EP1362587A1 Use of glutamine for treating low arginine levels in the animal or human body
11/19/2003EP1362586A1 Composition for the treatment of alcohol and smoking withdrawal
11/19/2003EP1362583A1 Process for masking the taste of substances by microencapsulation
11/19/2003EP1362581A2 Combination antiperspirant and antimicrobial compositions
11/19/2003EP1362518A1 Food product providing sustained blood levels of exogenous substances
11/19/2003EP1362511A1 Protective solution for preventing ischaemia
11/19/2003EP1362127A2 Serpin drugs for treatment of hiv infection and method of use thereof
11/19/2003EP1362119A1 Glucosamine and method of making glucosamine from microbial biomass
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1362053A2 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/19/2003EP1362052A1 Inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362050A1 Pyrimidine derivatives for inhibition of cell-proliferation
11/19/2003EP1362048A1 Triazolo compounds as mmp inhibitors
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362043A1 Lactone compounds as novel photoinitiators
11/19/2003EP1362042A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362038A1 Novel alkyl phenylimino-imidazolidine derivatives for treating urinary incontinence
11/19/2003EP1362034A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1362030A1 Novel benzoylguanidine salt
11/19/2003EP1362028A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361899A2 Devices and methods for the treatment of cancer
11/19/2003EP1361898A2 Modulated release particles for aerosol delivery
11/19/2003EP1361896A2 Localized myocardial injection method for treating ischemic myocardium
11/19/2003EP1361889A1 Novel vaccine
11/19/2003EP1361885A1 Use of $g(g)-gt inhibitors for the treatment of degenerative diseases
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP1361882A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/19/2003EP1361881A2 Steroid hormone products and methods for preparing them
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361879A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
11/19/2003EP1361878A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
11/19/2003EP1361877A1 Pharmaceutical dosage forms of epothilones for oral administration
11/19/2003EP1361876A2 Novel cannabimimetic ligands
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1361871A2 Medicament formulation containing a muscarinic agonist
11/19/2003EP1361870A2 A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
11/19/2003EP1361869A2 Transdermal therapeutic system containing testosterone and method for the production thereof
11/19/2003EP1361868A1 Novel modified release formulation
11/19/2003EP1361867A1 Fibrate-statin combinations with reduced fed-fasted effects
11/19/2003EP1361864A2 Mucoadhesive pharmaceutical formulations
11/19/2003EP1361863A2 Carotenoid-loaded liposomes
11/19/2003EP1361861A1 Modulated release particles for aerosol delivery
11/19/2003EP1361860A1 Modulated release particles for aerosol delivery
11/19/2003EP1361859A1 Modulated release particles for aerosol delivery
11/19/2003EP1361858A2 Modulated release particles for aerosol delivery
11/19/2003EP1361857A1 Modulated release particles for aerosol delivery
11/19/2003EP1361854A1 Topical solution containing a chromane or chromene derivative
11/19/2003EP1265601B1 Method for treating ocular pain
11/19/2003EP1240141B1 New modulators of dopamine neurotransmission
11/19/2003EP1220848B1 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv
11/19/2003EP1216250B1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists
11/19/2003EP1216249B1 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
11/19/2003EP1214080B1 Glucosamine and hyperimmune egg for reducing inflammation
11/19/2003EP1214076B1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
11/19/2003EP1196153B1 Process for the improvement of spermatozoa fertilization activity
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1178046B1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
11/19/2003EP1157023B1 C-21 modified epothilones
11/19/2003EP1124549B1 Water-miscible pharmaceutical compositions of paclitaxel
11/19/2003EP1121107B1 Sertraline oral concentrate
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP1117401B1 Antibiotic compositions for treatment of the eye
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
11/19/2003EP1011723B1 88kda tumorigenic growth factor and antagonists
11/19/2003EP1003738B1 Bicyclic compounds as ligands for 5-ht1 receptors
11/19/2003EP0996442B1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/19/2003EP0984970B1 Spiro-quinuclidine derivatives, their preparation and use
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0969839B1 Anhydrovinblastine for the treatment of cancer
11/19/2003EP0967997B1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
11/19/2003EP0956048B1 Stable compositions containing a retinoid and an enzyme based antioxidant system
11/19/2003EP0914111B1 Prevention and treatment of cachexia and anorexia
11/19/2003EP0912106B1 Agent for increasing the production of/in breeding and production mammals
11/19/2003EP0898571B1 Thieno-pyridine sulfonamides, derivatives thereof and related compounds that modulate the activity of endothelin
11/19/2003EP0874631B1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
11/19/2003EP0863880B1 Novel 1-ar(alk)yl-imidazolin-2-ones containing a disubstituted amine radical in the 4th position, having an anti-convulsive effect, and process for their production
11/19/2003EP0857173B1 Meiosis regulating compounds
11/19/2003EP0852226B1 Pyrimidine derivatives
11/19/2003EP0851753B1 Aerosol compositions
11/19/2003EP0831811B1 Carbazoles for treating microbial infections
11/19/2003EP0815144B1 Therapeutic uses of glucan
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0796849B1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof
11/19/2003EP0767673B1 Methods for reduced renal uptake of antibody fragments
11/19/2003EP0766559B1 Cannabinoid receptor antagonists
11/19/2003EP0756477B1 Methods for phototherapeutic treatment of proliferative skin diseases
1 ... 5272 5273 5274 5275 5276 5277 5278 5279 5280 5281 5282 5283 5284 5285 5286 5287 5288 5289 5290 5291 5292 ... 7860